Mutual Fund Ownership
Ownership as on: Mon, 25 Nov, 2024

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

NA
Equity
Amount Invested (Cr.)95.72
% of AUM1.91%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)19.57
% of AUM1.65%

ICICI Prudential Smallcap Fund Growth

2/5
Equity
Amount Invested (Cr.)61.29
% of AUM0.73%

ICICI Prudential Smallcap Fund Institutional Growth

3/5
Equity
Amount Invested (Cr.)61.29
% of AUM0.73%

FAQs about Windlas Biotech share price

Windlas Biotech is trading at 1042.75 as on Mon Nov 25 2024 09:59:52. This is 8.34% upper as compared to its previous closing price of 962.45.

The market capitalization of Windlas Biotech is 2009.98 Cr as on Mon Nov 25 2024 09:59:52.

The 52 wk high for Windlas Biotech is 1197.00 whereas the 52 wk low is 397.90

Windlas Biotech can be analyzed on the following key metrics -

  • TTM P/E: 28.45
  • Sector P/E: 40.12
  • Dividend Yield: 0.57%
  • D/E ratio: 0.04

Windlas Biotech reported a net profit of 58.19 Cr in 2024.

Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts